MS170 is a selective PROTAC designed to target and degrade AKT proteins. It effectively reduces overall cellular AKT levels through its binding interactions with AKT1, AKT2, and AKT3, showcasing its potential for modulating AKT signaling pathways.
Usually ships within 24 hours.